Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Leases (2019 - 2025)

Historic Current Leases for Standard Biotools (LAB) over the last 7 years, with Q3 2025 value amounting to $5.1 million.

  • Standard Biotools' Current Leases fell 1648.15% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 1648.15%. This contributed to the annual value of $4.8 million for FY2024, which is 1117.28% up from last year.
  • Per Standard Biotools' latest filing, its Current Leases stood at $5.1 million for Q3 2025, which was down 1648.15% from $5.1 million recorded in Q2 2025.
  • Standard Biotools' 5-year Current Leases high stood at $6.3 million for Q1 2025, and its period low was $2.9 million during Q3 2021.
  • Its 5-year average for Current Leases is $4.3 million, with a median of $3.9 million in 2023.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 15527.43% in 2021, then crashed by 1648.15% in 2025.
  • Over the past 5 years, Standard Biotools' Current Leases (Quarter) stood at $3.1 million in 2021, then rose by 20.6% to $3.7 million in 2022, then increased by 17.41% to $4.3 million in 2023, then rose by 11.17% to $4.8 million in 2024, then increased by 6.39% to $5.1 million in 2025.
  • Its Current Leases was $5.1 million in Q3 2025, compared to $5.1 million in Q2 2025 and $6.3 million in Q1 2025.